Indices of low-grade inflammation in polycystic ovary syndrome (Q36739203)

16 August 2017

1 reference

title

Indices of low-grade inflammation in polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

16 August 2017

0 references

1 reference

1 reference

Evanthia Diamanti-Kandarakis

series ordinal

1

object named as

Evanthia Diamanti-Kandarakis

1 reference

16 August 2017

Thomas Paterakis

2

1 reference

PubMed ID

17308143

16 August 2017

Helen A Kandarakis

series ordinal

3

1 reference

PubMed ID

17308143

16 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Annals of the New York Academy of Sciences

16 August 2017

1 reference

16 August 2017

1092

1 reference

16 August 2017

175-186

1 reference

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

16 August 2017

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Inflammatory markers and the risk of coronary heart disease in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Is type II diabetes mellitus a disease of the innate immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Insulin resistance and chronic cardiovascular inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Pathophysiological implications of insulin resistance on vascular endothelial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Metformin administration improves endothelial function in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Polycystic ovary syndrome: syndrome XX?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Cardiovascular risk in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Low grade chronic inflammation in women with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

The polycystic ovary syndrome per se is not associated with increased chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Leptin and the regulation of body weight in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Resistin and obesity-associated insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Serum resistin levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

Circulating E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in men with coronary artery disease assessed by angiography and disturbances of carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

The -597 G-->A and -174 G-->C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

TNF-alpha and hyperandrogenism: a clinical, biochemical, and molecular genetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.015

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1365.015

1 reference

16 August 2017

1 reference

PubMed ID

17308143